Information for Laboratories
This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).
Interim Guidance for Laboratories
Real-Time RT-PCR Resources
- Acceptable Commercial Primers and Probes pdf icon[1 Page]
- Processing of Sputum Specimens for Nucleic Acid Extraction pdf icon[1 page]
- CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel Instructions for Useexternal icon
- FAQ for Diagnostic Tools and Virus
- Information about COVID-19 diagnostic tests under FDA Emergency Use Authorizationexternal icon
- To request 2019-nCoV grown in cell culture, NIH’s BEI Resources Repositoryexternal icon
COVID-19 Lab Advisories and Alerts
- 05/04/2020: Lab Advisory: Join the Next Clinical Laboratory COVID-19 Response Weekly Call on Monday, May 4 at 3:00 PM EDT
- 05/02/2020: Lab Advisory: New LOINC In-Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results
- 05/01/2020: Lab Advisory: CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing
- 04/27/2020: Lab Advisory: Join the Next Clinical Laboratory COVID-19 Response Weekly Call on Monday, April 27 at 3:00 PM EDT
- 04/20/2020: Lab Update: COVID-19 Laboratory Testing and Reporting Q&As and Specimen Collection Guidance
Requests for COVID-19 Diagnostic Tools and Virus
COVID-19 Testing and Reporting by Laboratories: Q & A
SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)
Fact Sheets to Accompany 2019-nCoV Real-Time RT-PCR Diagnostic Panel Test Results
Additional Resources
Page last reviewed: April 21, 2020